|
Markt geschlossen -
Toronto S.E.
21:55:00 20.11.2026
|
Perf. 5 T | Veränd. 1. Jan. | ||
| 33.39 CAD | -0.60% |
|
-1.10% | +32.03% |
| 20.11. | Gilead Sciences, Inc. : Mizuho Securities bekräftigt seine Kaufempfehlung | ZM |
| 20.11. | Wissenschaftler erfahren mehr über das seltene Ebola-Virus beim Ausbruch im Kongo | RE |
Hauptkonkurrenten
| % | % 5 Tage | Veränd. 1 Monat | Veränd. 3 Monate | % 1. Jan. | Perf. 1 Jahr | Perf. 3 Jahre | Veränd. 5 Jahre | Veränd. 10 Jahre | Marktkap.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.30% | -6.68% | +4.94% | +8.25% | +25.35% | +29.12% | +125.42% | +416.73% | +1’657.02% | 1’204 Mrd. | ||
| +1.25% | -5.35% | +4.28% | +1.16% | +30.69% | +33.19% | +80.42% | +66.04% | +134.46% | 643 Mrd. | ||
| +0.94% | -2.99% | -1.00% | +9.31% | +25.26% | +24.73% | +106.93% | +146.21% | +372.90% | 501 Mrd. | ||
| -0.60% | -1.95% | +1.77% | +6.72% | +20.90% | +27.26% | +67.32% | +7.26% | +71.03% | 378 Mrd. | ||
| +0.69% | -9.50% | -9.83% | -10.25% | +27.04% | +40.80% | +30.23% | +65.70% | +116.13% | 327 Mrd. | ||
| +0.41% | -4.70% | +1.00% | +1.12% | +16.57% | +27.23% | +51.59% | +68.02% | +78.44% | 285 Mrd. | ||
| +0.81% | -4.08% | +6.29% | +10.95% | -2.74% | -1.74% | +32.71% | +58.18% | +210.21% | 270 Mrd. | ||
| -0.15% | -6.45% | -0.75% | +0.44% | +33.10% | +29.63% | +64.18% | +111.39% | +199.97% | 237 Mrd. | ||
| -0.06% | -0.98% | +6.34% | +16.03% | +35.60% | +33.15% | +118.99% | +142.29% | +123.04% | 207 Mrd. | ||
| -0.25% | -5.01% | +1.26% | -10.69% | -18.68% | -15.80% | -62.38% | -29.59% | +130.80% | 172 Mrd. | ||
| -0.51% | -5.16% | -9.00% | -1.40% | +10.04% | +12.30% | -8.61% | -46.06% | -12.96% | 157 Mrd. | ||
| -1.08% | -4.38% | +0.07% | -4.67% | +13.60% | +21.95% | +44.33% | +181.62% | +475.83% | 132 Mrd. | ||
| +0.68% | -3.03% | +3.82% | +27.50% | +30.37% | +25.90% | +136.09% | +384.12% | +663.61% | 123 Mrd. | ||
| +0.79% | -7.30% | -4.67% | -10.19% | +9.01% | +27.99% | +20.25% | +1.68% | +3.59% | 119 Mrd. | ||
| +1.35% | -3.06% | +15.41% | +9.17% | +2.66% | -0.47% | -0.59% | -4.48% | +11.66% | 110 Mrd. | ||
| +0.85% | -3.61% | -1.39% | -4.06% | +0.99% | +4.66% | +30.86% | -3.13% | -3.19% | 96.01 Mrd. | ||
| -0.19% | -3.64% | +14.02% | +11.38% | +19.28% | +24.92% | +14.85% | +41.06% | +131.63% | 92.66 Mrd. | ||
| -2.17% | -12.70% | -19.45% | +46.26% | +561.24% | +772.09% | +146.96% | -26.07% | - | 80.65 Mrd. | ||
| -2.16% | -1.00% | +10.56% | +0.11% | -13.76% | -14.12% | +45.68% | +72.88% | +548.24% | 74.78 Mrd. | ||
| Durchschnitt | +0.03% | -4.61% | +1.25% | +5.64% | +43.50% | +58.04% | +55.01% | +87.05% | +272.91% | 274 Mrd. | |
| Nach Marktkapitalisierung gewichteter Durchschnitt | +0.27% | -5.04% | +1.84% | +5.02% | +28.84% | +35.74% | +74.37% | +153.16% | +527.20% |
- Börse
- Aktien
- 885823 Aktie
- A417NL Aktie
- Sektor Gilead Sciences, Inc.
Bitte wählen Sie Ihre Edition
Alle länderspezifischen Finanzinformationen
















